A team of scientists from the University of California, San Francisco (UCSF) has identified how a key protein called IRGM1 keeps chronic infection in check. The findings, published in the journal Nature Immunology, could lead to new therapies for treating chronic infections such as HIV, hepatitis C, and tuberculosis.

IRGM1 is a protein that is produced by immune cells called macrophages. Macrophages are white blood cells that engulf and destroy foreign invaders such as bacteria and viruses. IRGM1 helps macrophages to kill bacteria by breaking down their cell walls.

In the study, the UCSF scientists showed that IRGM1 is essential for controlling chronic infection. Mice that were deficient in IRGM1 were more susceptible to chronic infection with the bacteria Salmonella typhimurium. The scientists found that IRGM1 deficiency led to impaired killing of bacteria by macrophages.

The scientists also showed that IRGM1 is important for controlling infection with the virus HIV. HIV infects macrophages, and IRGM1 deficiency led to increased replication of HIV in these cells.

The findings of this study suggest that IRGM1 is a critical component of the immune response to chronic infection. IRGM1 deficiency could lead to increased susceptibility to chronic infection, and new therapies that target IRGM1 could be used to treat chronic infections.

Background:

Chronic infection is a major public health problem. Worldwide, over 1 billion people are infected with chronic infections, and these infections are responsible for millions of deaths each year. Chronic infections can be caused by bacteria, viruses, fungi, and parasites.

Some chronic infections are treatable, but many are not. There is a need for new therapies to treat chronic infections.

Significance of the Study:

The findings of this study could lead to new therapies for treating chronic infections. IRGM1 is a critical component of the immune response to chronic infection, and IRGM1 deficiency could lead to increased susceptibility to chronic infection. New therapies that target IRGM1 could be used to treat chronic infections.

Next Steps:

The scientists plan to further investigate the role of IRGM1 in chronic infection. They also plan to develop new therapies that target IRGM1 for the treatment of chronic infections.